Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard vs Reduced Injections of onabotulinumtoxinA for Overactive Bladder
NCT04020510Phase 4Recruiting
- Sponsor
- Walter Reed National Military Medical Center
- Start
- Jul 2019
- Primary completion
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in overactive bladder (OAB), sponsored by Walter Reed National Military Medical Center. Started Jul 2019; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT04020510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04020510.